Fonte: Current Topics in Medicinal Chemistry. Unidade: FCF
Assuntos: MEDICAMENTO, METABOLISMO
ABNT
CUPPOLONI, Andréa et al. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, v. 23, n. 12, p. 1081-1089, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230207120752. Acesso em: 13 nov. 2024.APA
Cuppoloni, A., Silva, J. V. da, Snape, T. J., Lal, S., & Giarolla, J. (2023). 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations. Current Topics in Medicinal Chemistry, 23( 12), 1081-1089. doi:10.2174/1568026623666230207120752NLM
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026623666230207120752Vancouver
Cuppoloni A, Silva JV da, Snape TJ, Lal S, Giarolla J. 2,3-Diarylindoles as COX-2 Inhibitors: exploring the structure-activity relationship through molecular docking simulations [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 12): 1081-1089.[citado 2024 nov. 13 ] Available from: https://doi.org/10.2174/1568026623666230207120752